1. A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib. Issue 8 (August 2015) Authors: Tamiya, Akihiro; Shimizu, Shigeki; Atagi, Shinji Journal: Journal of thoracic oncology Issue: Volume 10:Issue 8(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease. (November 2018) Authors: Hanibuchi, Masaki; Kakiuchi, Soji; Atagi, Shinji; Ogushi, Fumitaka; Shimizu, Eiji; Haku, Takashi; Toyoda, Yuko; Azuma, Masahiko; Kondo, Mayo; Kawano, Hiroshi; Otsuka, Kenji; Sakaguchi, Satoshi; Nokihara, Hiroshi; Goto, Hisatsugu; Nishioka, Yasuhiko Journal: Lung cancer Issue: Volume 125(2018) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index. Issue 10 (23rd February 2022) Authors: Naito, Tateaki; Uchino, Junji; Kojima, Toru; Matano, Yutaka; Minato, Koichi; Tanaka, Kentaro; Mizukami, Takuro; Atagi, Shinji; Higashiguchi, Takashi; Muro, Kei; Takayama, Koichi; Furuse, Junji; Morishima, Eiichiro; Takiguchi, Toru; Tamura, Kazuo Journal: Cancer Issue: Volume 128:Issue 10(2022) Page Start: 2025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A quantitative evaluation of the histological type dependence of the programmed death-ligand 1 expression in non-small cell lung cancer including various adenocarcinoma subtypes: a cross-sectional study. (29th December 2021) Authors: Kojima, Kensuke; Sakamoto, Tetsuki; Kasai, Takahiko; Atagi, Shinji; Yoon, Hyungeun Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 3(2022) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations (JMTO LC12‐01). Issue 12 (13th May 2022) Authors: Asami, Kazuhiro; Ando, Masahiko; Nishimura, Takashi; Yokoi, Takashi; Tamura, Atsuhisa; Minato, Koichi; Mori, Masahide; Ogushi, Fumitaka; Yamamoto, Akiyoshi; Yoshioka, Hiroshige; Kawahara, Masaaki; Atagi, Shinji Journal: Thoracic cancer Issue: Volume 13:Issue 12(2022) Page Start: 1827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Assessment of ALK gene rearrangement in lung cancer using a new rapid automated SureFISH (Dako Omnis) assay. Issue 8 (6th March 2017) Authors: Takeda, Maiko; Kasai, Takahiko; Shimizu, Shigeki; Kitaichi, Masanori; Kojima, Kensuke; Nagoya, Akihiro; Hayashi, Akio; Utsumi, Tomoki; Yoon, Hyung-Eun; Matsumura, Akihide; Atagi, Shinji Journal: Journal of clinical pathology Issue: Volume 70:Issue 8(2017) Page Start: 712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cytopathological Features of SMARCA4-Deficient Thoracic Sarcoma: Report of 2 Cases and Review of the Literature. (February 2020) Authors: Takeda, Maiko; Tani, Yoko; Saijo, Nobuhiko; Shimizu, Shigeki; Taniguchi, Yoshihiko; Otsuka, Kenji; Nakao, Keiko; Tamiya, Akihiro; Okishio, Kyoichi; Atagi, Shinji; Ohbayashi, Chiho; Kasai, Takahiko Journal: International journal of surgical pathology Issue: Volume 28:Number 1(2020) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: Expanded cohort of the SOLUTION study. (March 2022) Authors: Murakami, Haruyasu; Horinouchi, Hidehito; Harada, Hideyuki; Sobue, Tomotaka; Kato, Tomohiro; Atagi, Shinji; Kozuki, Toshiyuki; Tokito, Takaaki; Oizumi, Satoshi; Seike, Masahiro; Ohashi, Kadoaki; Mio, Tadashi; Sone, Takashi; Jinushi, Masahisa; Tsuboi, Masahiro Journal: Lung cancer Issue: Volume 165(2022) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019) Authors: Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer. Issue 5 (26th April 2017) Authors: Hida, Toyoaki; Nishio, Makoto; Nogami, Naoyuki; Ohe, Yuichiro; Nokihara, Hiroshi; Sakai, Hiroshi; Satouchi, Miyako; Nakagawa, Kazuhiko; Takenoyama, Mitsuhiro; Isobe, Hiroshi; Fujita, Shiro; Tanaka, Hiroshi; Minato, Koichi; Takahashi, Toshiaki; Maemondo, Makoto; Takeda, Koji; Saka, Hideo; Goto, Ko... Journal: Cancer science Issue: Volume 108:Issue 5(2017) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗